The stock of HCA Healthcare Inc. (NYSE:HCA) increased by $0.69 on Friday to finish at $273.28, up 0.25 percent. The last five days have seen an average of 1,121,540 shares of common stock traded. 21 times new highs were reached in the current year, with a gain of $33.32. The average number of shares traded over the last 20 days was 1,095,750, while the average volume over the last 50 days totaled 1,326,724.
HCA stock dropped -1.10% since last month. On 08/18/23, the company’s shares reached a one-month low of $264.30. The stock touched a high of $304.86 on 06/30/23, after rallying from a low of $178.32 in 52 weeks. The price of HCA stock has risen by 13.89% or $33.32 this year, reaching a new high 21 times. Still, the stock price is down -10.36% from the 52-week high.
Insider Transactions
HCA stock investors should be aware that HCA Healthcare Inc. (HCA) stock had its last reported insider trading activity 14 days ago on Aug 14. On Aug 14, SVP-Payer Contracting & Align. Torres Kathryn A. sold 5,204 shares at $269.12 each. This transaction resulted in the insider making $1,400,516. On Aug 11, Cohen Jeffrey E. sold 1,500 shares at a price of US$270.00. After the transaction, the insider now owns 4,414 shares. SVP & Chief Ethics Officer Whalen Kathleen M had earlier sold 2,916 shares on Aug 03 for $270.00 a share. The transaction was completed for $787,320.
Valuation Metrics
HCA Healthcare Inc. (HCA) has a trailing price-to-earnings (P/E) ratio of 13.44. Beta for the stock is 1.59. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 1.20, and the price-to-cash flow ratio of 15.03.
Company paid $0.60 per share in dividends, remained unchanged from $0.60 last year.
Financial Health
For the three months ended June 29, HCA Healthcare Inc.’s quick ratio was 1.00, while its current ratio was 1.20, indicating its ability to pay off its debt. As far as profitability goes, gross margin for the trailing twelve months is 84.40% percent. HCA Healthcare Inc.’s EBITDA margin for the year ended June 29 was 19.96%, whereas its operating margin stood at 15.00% for the same period. Based on annual data, it had gross profit of $50.86 billion and revenue of $60.23 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. HCA’s return on assets (ROA) during the last 12 months has been 11.00%. There was a 20.50% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -211.10%.
Earnings Surprise
According to HCA Healthcare Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $15.86 billion, while revenues rose by 6.56% to $15.59 billion. It was predicted that HCA Healthcare Inc.’s quarterly earnings would be $4.29, but it ended up being $4.22, beating the consensus by 1.70%. EBITDA was $3.06 billion for the quarter. At the end of HCA Healthcare Inc.’s most recent quarter ended June 29, its liabilities totaled 53.13 billion, while its total debt was $40.74 billion. Equity owned by shareholders amounts to $271.99 million.
Technical Picture
Here’s a quick look at HCA Healthcare Inc.’s (HCA) price momentum from a technical perspective. As of 25 August, the RSI 9-day stood at 50.96%, suggesting the stock is Neutral, with a 17.50% historical volatility rate.
The stochastic %K and %D were 68.80% and 77.84% respectively, while the average true range (ATR) was 4.92. Based on the 14-day stochastic reading of 57.31%, the RSI (14) reading is 47.63%. On the 9-day MACD Oscillator, the stock is at 2.88, and the 14-day reading is at 3.89.
Analyst Ratings
In its analyst report released on April 21, 2023, Cantor Fitzgerald began covering HCA Healthcare Inc. (NYSE: HCA). The stock was rated as an Overweight by the brokerage firm. Analysts have assigned HCA Healthcare Inc. (HCA) an Overweight rating. HCA is a stock that is recommended for selling by 0 brokerage firms, while 5 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 3 rates it overweight and 16 others recommend it as a buy.
What is HCA’s price target for the next 12 months?
The current consensus forecast for the stock is between $275.00 and $350.00, with a median target price of $324.00. In analyzing these forecasts, the average price target given by analysts for HCA Healthcare Inc. (HCA) is $321.48.
